June 15, 2020 / 12:18 PM / 2 months ago

BRIEF-Abbott's Freestyle Libre 2 Cleared In U.S. For Adults And Children With Diabetes

June 15 (Reuters) - Abbott Laboratories:

* ABBOTT’S FREESTYLE® LIBRE 2 ICGM CLEARED IN U.S. FOR ADULTS AND CHILDREN WITH DIABETES, ACHIEVING HIGHEST LEVEL OF ACCURACY AND PERFORMANCE STANDARDS

* ABBOTT LABORATORIES - WILL OFFER NEW SYSTEM AT SAME PRICE AS CURRENTLY AVAILABLE FREESTYLE LIBRE 14 DAY SYSTEM

* ABBOTT- FREESTYLE LIBRE 2 SYSTEM WILL BE AVAILABLE IN COMING WEEKS AT PARTICIPATING PHARMACIES AND DURABLE MEDICAL EQUIPMENT SUPPLIERS ACROSS U.S.

* ABBOTT - FREESTYLE LIBRE 2 SYSTEM TO BE AVAILABLE IN COMING WEEKS AT PARTICIPATING PHARMACIES, DURABLE MEDICAL EQUIPMENT SUPPLIERS ACROSS U.S. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below